Akebia Therapeutics (AKBA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AKBA | TAK | ZTS | ONC | UTHR |
| Company | Akebia Therapeutics | Takeda Pharmaceutical Ltd ADR | Zoetis Inc Cl A | Beone Medicines Ltd | United Therapeutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NASDAQ | NASDAQ |
| Open | 1.3700 | 18.26 | 117.11 | 311.30 | 566.14 |
| High | 1.4000 | 18.34 | 118.39 | 311.66 | 567.39 |
| Low | 1.3200 | 18.16 | 116.80 | 301.34 | 552.54 |
| Latest | 1.3200 | 18.22 | 118.26 | 302.49 | 559.65 |
| Change | -0.0600 | -0.52 | +0.32 | -8.30 | -5.16 |
| % Change | -4.35% | -2.77% | +0.27% | -2.67% | -0.91% |
| Volume | 2,359,923 | 3,584,066 | 1,722,362 | 202,017 | 479,662 |
| 20-Day Average Volume | 2,707,286 | 2,894,708 | 3,941,218 | 214,521 | 752,308 |
| Previous Close | 1.3800 | 18.74 | 117.94 | 310.79 | 564.81 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.3985 | 18.16 | 117.42 | 289.49 | 543.03 |
| 20-Day Raw Stochastic | 21.31% | 42.06% | 51.37% | 69.71% | 57.08% |
| 20-Day Relative Strength | 45.83 | 53.14 | 46.22 | 48.63 | 58.28 |
| Weighted Alpha | -37.61 | +34.51 | -23.10 | +20.03 | +83.01 |
| Today's Opinion | 72% Sell | 100% Buy | 88% Sell | 56% Sell | 100% Buy |
| Previous Opinion | 56% Sell | 100% Buy | 88% Sell | 56% Sell | 100% Buy |
| Last Month's Opinion | 100% Sell | 80% Buy | 80% Sell | 8% Buy | 72% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.49% since 03/27/26 | +1.73% since 03/27/26 | +4.33% since 03/27/26 | +6.88% since 03/27/26 | +7.04% since 03/27/26 |
| Low | 1.3000 on 03/30/26 | 18.14 on 03/30/26 | 113.58 on 03/30/26 | 281.13 on 03/30/26 | 551.30 on 04/02/26 |
| High | 1.4600 on 04/01/26 | 18.90 on 04/01/26 | 118.89 on 04/01/26 | 315.97 on 04/02/26 | 607.89 on 03/30/26 |
| 1-Month | |||||
| %Chg | +3.94% since 03/06/26 | +1.90% since 03/06/26 | -2.61% since 03/06/26 | +0.45% since 03/06/26 | +17.04% since 03/06/26 |
| Low | 1.2550 on 03/09/26 | 17.73 on 03/09/26 | 113.29 on 03/27/26 | 271.47 on 03/24/26 | 495.50 on 03/09/26 |
| High | 1.5600 on 03/17/26 | 18.90 on 04/01/26 | 122.96 on 03/10/26 | 315.97 on 04/02/26 | 607.89 on 03/30/26 |
| 3-Month | |||||
| %Chg | -10.20% since 01/06/26 | +15.39% since 01/06/26 | -8.57% since 01/06/26 | -5.58% since 01/06/26 | +11.33% since 01/06/26 |
| Low | 1.1400 on 02/20/26 | 15.78 on 01/21/26 | 113.29 on 03/27/26 | 271.47 on 03/24/26 | 455.63 on 01/20/26 |
| High | 1.6000 on 02/12/26 | 18.90 on 04/01/26 | 132.49 on 02/12/26 | 372.73 on 02/24/26 | 607.89 on 03/30/26 |
| 6-Month | |||||
| %Chg | -55.56% since 10/06/25 | +25.22% since 10/06/25 | -18.64% since 10/06/25 | -12.20% since 10/06/25 | +23.47% since 10/06/25 |
| Low | 1.1400 on 02/20/26 | 12.99 on 10/30/25 | 113.29 on 03/27/26 | 271.47 on 03/24/26 | 409.07 on 10/28/25 |
| High | 3.2000 on 10/28/25 | 18.90 on 04/01/26 | 148.30 on 10/22/25 | 385.22 on 11/17/25 | 607.89 on 03/30/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 369,673 | 59,638,344 | 49,785,776 | 34,099,880 | 24,754,488 |
| Shares Outstanding, K | 267,879 | 3,182,409 | 422,128 | 109,720 | 43,828 |
| Annual Sales | 236,200,000 | 30,238,240,000 | 9,467,000,000 | 5,343,030,000 | 3,182,700,000 |
| Annual Net Income | -5,350,000 | 712,320,000 | 2,673,000,000 | 286,930,000 | 1,334,700,000 |
| Last Quarter Sales | 57,620,000 | 7,736,500,000 | 2,387,000,000 | 1,498,170,000 | 790,200,000 |
| Last Quarter Net Income | -12,240,000 | 672,830,000 | 603,000,000 | 66,500,000 | 364,300,000 |
| 60-Month Beta | 0.37 | -0.01 | 0.98 | 0.53 | 0.75 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.05 on 02/26/26 | 0.48 on 01/29/26 | 1.48 on 02/12/26 | 0.58 on 02/26/26 | 7.70 on 02/25/26 |
| Latest Earnings Date | 05/14/26 | 05/14/26 | 05/05/26 | 05/06/26 | 04/29/26 |
| Most Recent Dividend | N/A | 0.252 on 09/30/25 | 0.530 on 01/20/26 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 09/30/25 | 04/20/26 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 11.73 | 18.27 | 82.69 | 20.44 |